Literature DB >> 7152672

Failure of phorbol myristate acetate to damage DNA in leukocytes from patients with chronic granulomatous disease.

H C Birnboim, W D Biggar.   

Abstract

Unlike leukocytes from normal donors, leukocytes from patients with chronic granulomatous disease do not suffer DNA damage on exposure to the tumor promoter, phorbol myristate acetate.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7152672      PMCID： PMC347890          DOI： 10.1128/iai.38.3.1299-1300.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  6 in total

1.  Defective superoxide production by granulocytes from patients with chronic granulomatous disease.

Authors:  J T Curnutte; D M Whitten; B M Babior
Journal:  N Engl J Med       Date:  1974-03-14       Impact factor: 91.245

2.  DNA strand breakage in human leukocytes exposed to a tumor promoter, phorbol myristate acetate.

Authors:  H C Birnboim
Journal:  Science       Date:  1982-03-05       Impact factor: 47.728

3.  Fluorometric method for rapid detection of DNA strand breaks in human white blood cells produced by low doses of radiation.

Authors:  H C Birnboim; J J Jevcak
Journal:  Cancer Res       Date:  1981-05       Impact factor: 12.701

4.  NADPH oxidase deficiency in X-linked chronic granulomatous disease.

Authors:  D C Hohn; R I Lehrer
Journal:  J Clin Invest       Date:  1975-04       Impact factor: 14.808

5.  Leukocyte oxidase: defective activity in chronic granulomatous disease.

Authors:  R L Baehner; D G Nathan
Journal:  Science       Date:  1967-02-17       Impact factor: 47.728

6.  Defects in the oxidative killing of microorganisms by phagocytic leukocytes.

Authors:  D Roos; R S Weening
Journal:  Ciba Found Symp       Date:  1978 Jun 6-8
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.